# Midatech Pharma to appoint Dr. Stephen Parker as non-executive Chairman of the Board

- Link: https://www.directorstalkinterviews.com/midatech-pharma-to-appoint-dr.stephen-parker-as-non-executive-chairman-of-the-board/4121068014
- Published: 2022-06-10T07:05:44+01:00
- Author: Amilia Stone

**Midatech Pharma PLC** (LON:MTPH), an R&D biotechnology company focused on improving
the bio-delivery and biodistribution of medicines, announces that Rolf Stahel, Chairman
and non-executive director, intends to retire after the Company’s Annual General
Meeting on 20 June 2022.  It is expected that Dr. Stephen Parker will be appointed
as non-executive Chairman of the Board, following the AGM.

Stephen Parker has over 30 years’ experience in leadership roles both in the healthcare
industry and in advisory roles. Currently, he is Chairman of Sareum Holdings plc(
AIM: SAR) and Drishti Discoveries Ltd, a Non-Executive Director of MGC Pharmaceuticals
Ltd (LON: MXC) and an Executive Director of sp^(2) Consulting Limited.  Previously,
Stephen held a number of executive and board positions at various public and private
biotech companies and senior roles at leading investment banks.  Stephen has an 
MBA from City University and a D.Phil. in biochemistry from Oxford University.

> **Commenting, Stephen Stamp, CEO and CFO of Midatech, said:** “On behalf of all
> stakeholders I would like to thank Rolf for his contribution to Midatech over 
> the last seven years and, from a personal perspective, for his leadership and 
> counsel during my tenure over the last two years.  We wish him well in his much
> deserved retirement.  I should also like to welcome Stephen to the Board.  Stephen’s
> broad experience both as an executive in, and senior adviser to, the industry 
> will be invaluable to Midatech in the next stage of the Company’s evolution.  
> I am very much looking forward to working with Stephen.”

> **Commenting, Stephen Parker, said:** “It is a great pleasure to be proposed as
> a director, and Chairman, of Midatech, whose technology base I have long admired.
> It is a particular privilege to be asked to succeed Rolf Stahel and I join Stephen
> in thanking Rolf for his leadership to date.  I look forward to working with the
> Midatech Board and team.”

> **Commenting, Rolf Stahel, added:** “I am handing over the Chairman function to
> Stephen Parker whose proposed appointment has the unanimous support from the directors
> of Midatech.  I have full confidence that Stephen Parker and Stephen Stamp, together
> with the other non-executive directors will form a powerful team leading Midatech
> to its promising future.  I would like to thank all stakeholders for the support
> I have received over the last seven years.”

Share on:
